ResMed AirSense 11 is a user-friendly CPAP machine that combines advanced technology with proven therapy modes1-3 designed for easy and quality sleep apnea therapy treatment.
Auto-adjusting machine that changes airflow pressure levels on a breath-by-breath basis. It also includes the AutoSet for Her algorithm.
Fixed pressure machine that delivers one consistent pressure.
AirSense™ 11 is ResMed’s next generation of sleep apnea therapy, combining our proven1-3 algorithms and technologies with the latest digital innovations. Its sleek design compliments any bedroom and supports users in feeling more confident about their treatment. The desired result is a more comfortable and user-friendly experience for customers, designed to empower them to start with confidence, achieve therapy adherence and better clinical outcomes.
ResMed Air Solutions is our ecosystem that includes AirSense 11, AirFit™ and AirTouch™ masks, and digital offerings such as ResMed AirView, our remote monitoring platform, and myAir, our patient engagement app. These work seamlessly together to support in delivering an optimised therapy experience for your customers and have been proven to help users acclimate and adhere to therapy.
Malhotra et al. “Patient engagement using new technology to improve adherence to positive airway pressure therapy: A retrospective analysis,” CHEST, 2018; 153(4):843-850.
Massie CA et al. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med 2003;167:20-23.
Netzel T et al. APAP device technology and correlation with patient compliance. Somnologie 2014;18(2):113-120.
Armistead JP et al. Study of an auto-adjusting CPAP algorithm for the treatment of obstructive sleep apnoea. Am J Respir Crit Care Med 2009;179:A3570.
† AutoSet for Her algorithm is available in the AirSense 11 AutoSet device only.
‡ The myAir by ResMed app is available in English in Australia and New Zealand.
* Care Check-In data is available in AirView upon customer consent.
˄ Over-the-air updates require cellular connectivity. Cellular connectivity depends on network availability.
± AutoSet response is available in the AirSense 11 AutoSet device only.
†† Some features of ResMed myAir are only available in the myAir app.
** As defined by CMS criteria within the first 3 months of initial PAP therapy use: > 4 h/n, at least 70% of nights, during a consecutive 30-day period.
≠ myAir requires cellular connectivity.
* Cellular connectivity depends on network availability